Male Contraceptive Gel to Be Evaluated in Clinical Trial

[MPR, 11/29/18] The safety and efficacy of a male contraceptive gel, developed by the Population Council and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), will be evaluated in a clinical trial to determine its ability to prevent pregnancy.

The year-long Phase 2b trial, funded by the National Institutes of Health, will enroll approximately 420 couples that are seeking pregnancy prevention across 3 US sites (Los Angeles, Seattle, and Kansas City). Future trial sites will include Chile, England, Italy, Kenya, Scotland, and Sweden.

The NES/T gel is composed of Nestorone (segesterone acetate), a progestin hormone used for female contraception, and testosterone. The transparent gel is intended to be absorbed through the skin on the upper arms and shoulders and works by reducing sperm production while maintaining normal sex drive. The trial will also examine the acceptability of the daily gel as a contraceptive method among the study couples……..

Read the Full Article at: MPR

Read more of the web’s hottest women’s health news @

We would LOVE to hear what your think about this article in the “Leave a Reply” section below.  Let’s get the conversion going….

2 responses to Male Contraceptive Gel to Be Evaluated in Clinical Trial

  1. Ana Santos December 3rd, 2018 at 2:48 pm

    It is about time! I was just talking to a friend of mine the other day and asked her “why are there not better men’s birth control option out” and here we go…. I am sharing this article with my boyfriend!


  2. Sasha Washington December 4th, 2018 at 10:11 am

    I am going to get my man on this quick.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.